Nektar Therapeutics NKTR Preferred Stock, Shares Outstanding
Preferred Stock, Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Nektar Therapeutics's preferred stock, shares outstanding?
- Nektar Therapeutics (NKTR) reported preferred stock, shares outstanding of $0 in Q1 2026.